Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome

被引:78
作者
Milberg, Peter
Tegelkamp, Regina
Osada, Nani
Schimpf, Rainer
Wolpert, Christian
Breithardt, Guenter
Borggrefe, Martin
Eckardt, Lars
机构
[1] Hosp Westfal Wilhelms Univ, Dept Cardiol & Angiol, Munster, Germany
[2] Univ Munster, Dept Med Informat & Biomath, D-4400 Munster, Germany
[3] Univ Heidelberg, Dept Med Cardiol, Univ Hosp Mannheim, Fac Clin Med, Heidelberg, Germany
关键词
short QT syndrome; ventricular fibrillation; refractory period; postrepolarization refractoriness; dispersion of repolarization;
D O I
10.1111/j.1540-8167.2007.00813.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Electrophysiologic Effects of Quinidine in SQTS. Background: Short QT syndrome (SQTS) is a newly described ion channelopathy, characterized by a short QT interval resulting from an accelerated cardiac repolarization, associated with syncope, atrial fibrillation, and sudden cardiac death due to ventricular fibrillation. As therapeutic options in SQTS are still controversial, we examined antiarrhythmic mechanisms in an experimental model of SQTS. Methods and Results: Pinacidil, an IK-ATP channel opener, was administered in increasing concentrations (50-100 mu M) in 48 Langendorff-perfused rabbit hearts and led to a significant reduction of action potential duration and QT interval, thereby mimicking SQTS. Eight simultaneously recorded monophasic action potentials demonstrated an increase in dispersion of repolarization, especially between the left and the right ventricle. During programmed ventricular stimulation with up to two extrastimuli, pinacidil significantly increased the inducibility of ventricular fibrillation (1 heart under baseline conditions, 29 hearts during pinacidil administration; P = 0.0001). Additional treatment with the I-Kr blocker sotalol (100 mu M) and the class I antiarrhythmic drugs flecainide (2 mu M) and quinidine (0.5 mu M) randomly assigned to three groups of 16 hearts led to prolongation of repolarization as well as refractory period. Sotalol or flecainide did not reduce the rate of inducibility of ventricular fibrillation significantly (P = 0.63; P = 0.219). However, quinidine reduced the inducibility of ventricular fibrillation by 73% (P = 0.008). The antiarrhythmic potential of quinidine was associated with a significantly greater prolongation of MAP duration, refractoriness, and postrepolarization refractoriness (PRR) as compared with sotalol and flecainide. Moreover, quinidine, in contrast to sotalol and flecainide, reduced dispersion of repolarization. Conclusion: Pinacidil mimics SQTS via increasing potassium outward currents, thereby facilitating inducibility of ventricular fibrillation. Quinidine demonstrates superior antiarrhythmic properties in the treatment of ventricular fibrillation in this model as compared with sotalol and flecainide because of its effects on refractoriness, PRR, and by reducing dispersion of repolarization.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 31 条
[1]   ELECTROPHYSIOLOGIC EVALUATION OF CARDIOVASCULAR AGENTS IN THE ISOLATED INTACT RABBIT HEART [J].
BALDERSTON, SM ;
JOHNSON, KE ;
REITER, MJ .
JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 25 (03) :205-213
[2]   Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome [J].
Belhassen, B ;
Viskin, S ;
Fish, R ;
Glick, A ;
Setbon, I ;
Eldar, M .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (10) :1301-1312
[3]   Mutation in the KCNQ1 gene leading to the short QT-interval syndrome [J].
Bellocq, C ;
van Ginneken, ACG ;
Bezzina, CR ;
Alders, M ;
Escande, D ;
Mannens, MMAM ;
Baró, I ;
Wilde, AAM .
CIRCULATION, 2004, 109 (20) :2394-2397
[4]   Short QT syndrome [J].
Bjerregaard, P ;
Gussak, I .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2005, 10 (04) :436-440
[5]   Short QT syndrome [J].
Brugada, R ;
Hong, K ;
Cordeiro, JM ;
Dumaine, R .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (11) :1349-1354
[6]   Sudden death associated with short-QT syndrome linked to mutations in HERG [J].
Brugada, R ;
Hong, K ;
Dumaine, R ;
Cordeiro, J ;
Gaita, F ;
Borggrefe, M ;
Menendez, TM ;
Brugada, J ;
Pollevick, GD ;
Wolpert, C ;
Burashnikov, E ;
Matsuo, K ;
Wu, YS ;
Guerchicoff, A ;
Bianchi, F ;
Giustetto, C ;
Schimpf, R ;
Brugada, P ;
Antzelevitch, C .
CIRCULATION, 2004, 109 (01) :30-35
[7]   The short OT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation [J].
Cerrone, M ;
Noujaim, S ;
Jalife, J .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (01) :24-38
[8]   KCNQ1 gain-of-function mutation in familial atrial fibrillation [J].
Chen, YH ;
Xu, SJ ;
Bendahhou, S ;
Wang, XL ;
Wang, Y ;
Xu, WY ;
Jin, HW ;
Sun, H ;
Su, XY ;
Zhuang, QN ;
Yang, YQ ;
Li, YB ;
Liu, Y ;
Xu, HJ ;
Li, XF ;
Ma, N ;
Mou, CP ;
Chen, Z ;
Barhanin, J ;
Huang, W .
SCIENCE, 2003, 299 (5604) :251-254
[9]   PINACIDIL-INDUCED ELECTRICAL HETEROGENEITY AND EXTRASYSTOLIC ACTIVITY IN CANINE VENTRICULAR TISSUES - DOES ACTIVATION OF ATP-REGULATED POTASSIUM CURRENT PROMOTE PHASE-2 REENTRY [J].
DIDIEGO, JM ;
ANTZELEVITCH, C .
CIRCULATION, 1993, 88 (03) :1177-1189
[10]   Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart [J].
Eckardt, L ;
Haverkamp, W ;
Gottker, U ;
Madeja, M ;
Johna, R ;
Borggrefe, M ;
Breithardt, G .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (04) :366-383